Potential therapeutic and pharmacological strategies for SARS-CoV2

BACKGROUND: At the end of 2019, the new Coronavirus disease 2019 (COVID-19) strain causing severe acute respiratory syndrome swept the world. From November 2019 till February 2021, this virus infected nearly 104 million, with more than two million deaths and about 25 million active cases. This has p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Pharm Investig
Autori principali: Ghareeb, Doaa A., Saleh, Samar R., Nofal, Mohammed S., Kaddah, Mohamed M. Y., Hassan, Salma. F., Seif, Inas K., El-Zahaby, Sally A., Khedr, Shaimaa M., Kenawy, Marwa Y., Masoud, Aliaa A., Soudi, Salma A., Sobhy, Ahmed A., Sery, Jaillan G., El-Wahab, Miral G. Abd, Elmoneam, Alshimaa A. Abd, Al-mahallawi, Abdulaziz Mohsen, El-Demellawy, Maha A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Singapore 2021
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933375/
https://ncbi.nlm.nih.gov/pubmed/33688448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40005-021-00520-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi